Worth mentioning, CD95‐resistant tumors may exploit the non‐cell death signaling capabilities of CD95 to promote proliferation and cell migration of tumor cells and CD95L expression to escape the immune system [10]. This evidence concerns the gene FASLG and neoplasm.